Are any other educational institutions confronting a problem w. AHA
patent policy and how are you handling?  As a major funder of
biomedical research I assume we are not the firt institution to
encounter a conflict w/ federal policy.  Specifically in question is
AHA's right to require assignment of patent and IP rights,
cancellation of any exclusive licenses, and granting of licenses on a
non-exclusive, royalty free basis?  Thanks in advance.
--

Mary Norton, Director
Bio Med Research Administration
Brown University
Box G-A322
Providence RI 02912
401/863-1631 (phone)
401/863-3378 (fax)
email: xxxxxx@brown.edu
http://biomed.brown.edu/Administration/BMRA/

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================